NATURE OF THE BUSINESS (Details Narrative) - shares |
9 Months Ended | |
|---|---|---|
Sep. 30, 2021 |
Sep. 20, 2018 |
|
| Merger Agreement Description | On August 9, 2018, the Board of Directors of the Company through its wholly-owned subsidiary NuLife Acquisition Corp. (“NuLife Sub”) approved and executed an agreement of merger and plan of reorganization with LJR (the “Merger Agreement”). Pursuant to the terms of the Merger Agreement, NuLife Sub merged with and into LJR, with LJR being the surviving entity and becoming the wholly-owned subsidiary of the Company, and all one hundred (100) issued and outstanding shares of common stock of LJR, held by the sole stockholder of LJR (the “LJR Stockholder”) were exchanged into one thousand (1,000) shares of series D senior convertible preferred stock, par value $.001 per share (the “Series D Preferred Stock”) of the Company, convertible into fifty million two hundred thirty-three thousand five hundred forty-one (50,239,541) shares of common stock of the Company. In addition, the LJR Stockholder received one share of series C super-voting preferred stock of the Company which granted the holder 50.1% of the votes of the Company at all times. | |
| Board of Directors [Member] | Preferred Stock Series D [Member] | ||
| Preferred stock, designated shares | 1,000 | |
| Board of Directors [Member] | Preferred Stock Series C [Member] | ||
| Preferred stock, designated shares | 1 |